The BioTrinity 2013 programme takes place over three days from 18:00 on May 14th to 16:30 on May 16th and includes an additional third parallel track so that we will now feature up to 100 hand-picked company showcase presentations from Europe's best biotech and medtech companies; nine key opinion leader investor and pharma panel discussions covering the choices for financing and exits for life sciences companies, whether that be corporate venture/VC/equity financing, licensing deals or pharma acquisition, discusses notables success stories and how they were achieved; and, includes interactive workshops to update you on the latest industry trends and advice, including a new "What Pharma Wants?" workshop series in which pharma licensing execs tell you exactly what they are looking for.
New for BioTrinity 2013 is the UK presentation of Ernst & Young’s Beyond Borders Global Biotechnology Report 2013.
If you wish us to consider including your company in the list of showcase presentations in 2013, contact Jon Rees for more information.
For more details on the conference please see the Preliminary Programme.
More detail about the 2013 agenda:
Once again for 2013, we have increased the number of private partnering rooms. New for 2013, partnering will be available on the Tuesday evening (May 14: 18:00-20:00) during the Grand Opening Reception. Details of the many networking opportunities can be found in the social programme including the Gala Dinner on the evening of May 15.